France· FR:61999103
INHIXA 8 000 UI (80 mg) dans 0,8 mL, solution injectable en seringue préremplie
A enoxaparin product containing énoxaparine sodique, registered in France by TECHDOW PHARMA NETHERLANDS (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Enoxaparin is registered in 16 of 19 countries.
Countries holding a registration under ATC B01AB05 (enoxaparin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Enoxaparin · ATC B01AB05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉNOXAPARINE SODIQUE
- Manufacturer
- TECHDOW PHARMA NETHERLANDS (PAYS-BAS)
- Country
- France (FR)
- ATC code
- B01AB05
- ATC class
- Enoxaparin
- Defined daily dose
- 2 TSD, E
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009301297912 seringue(s) préremplie(s) de 0,8 ml avec protège-aiguilleEUR 10.99
- cip13340093012980710 seringue(s) préremplie(s) de 0,8 ml avec protège-aiguilleEUR 54.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for enoxaparin.
Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Enoxaparin · interactions on record
203 records
- 106 severe
- 73 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Enoxaparin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArovi 100mg/1ml solution for injection pre-filled syringesROVI Biotech Ltd
- SwitzerlandClexane
- ItalyCLEXANE T*10 siringhe SC 10.000 UI 1 mlSANOFI Srl
- SpainCLEXANE 10.000 UI (100 mg)/ 1 ml SOLUCION INYECTABLE EN JERINGA PRECARGADASanofi Aventis S.A.
- PolandClexaneSanofi Winthrop Industrie
- NetherlandsEnoxaparine Becat 10.000 IE (100 mg)/1 ml oplossing voor injectie in een voorgevulde spuitLaboratorios Farmaceuticos Rovi, S.A.
- IcelandEnoxaparin LedraxenVENIPHARM
- SwedenEnoxaparin Ledraxen 10 000 IE (100 mg)/1 ml Injektionsvätska, lösning i förfylld sprutaVENIPHARM
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf5ddf55-0440-4fe7-8d86-a30403d9863d GET /v1/drugs/cf5ddf55-0440-4fe7-8d86-a30403d9863d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61999103",
"date_amm": "2016-09-15",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1132",
"substance": "ÉNOXAPARINE SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse;sous-cutanée;voie extracorporelle autre",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about enoxaparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.